Our MORE GREEN pillar encompasses environmental initiatives that consider many different aspects. Click here to learn more about our MORE GREEN pillar.
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. Click here for a media overview.
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Click here to download Boehringer Ingelheim's 2025 Manifesto detailing the long term initiative to improve health around the world for all communities.